PERSPECTA

News from every angle

← Back to headlines

NEXGEL Projects $35M Annual Revenue After Celularity Acquisition

NEXGEL anticipates achieving approximately $35 million in pro forma annual revenue following its acquisition of Celularity's wound segment.

21 Apr, 23:31 — 21 Apr, 23:31
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed32d ago

NEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition

Read full article →

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

just now

Hallgeir Kvadsheim Discusses Saving for Children

7h ago

Analyzing XLE ETF for Summer Investment Portfolios

22h ago

Financial Advice: Setting Up Super Accounts for Pre-Teen Children

1d ago